CENX News Alert Century Aluminum Company (CENX) 27.90 11/18/2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 9:45 PM

Century Aluminum Company (CENX) 27.90 $CENX

Comparing America's 3 Largest Aluminum Companies
Joseph Cafariello - at Seeking Alpha - Tue Nov 18, 2:21PM CST

CENX: 27.90 (+0.81), AA: 17.16 (+0.33), KALU: 72.78 (+0.13)

Stocks Stay Positive; GoPro, Ambarella Soar
at Investor's Business Daily - Tue Nov 18, 11:06AM CST
Stocks were off morning highs but still firmly positive heading into the lunch hour Tuesday. The Nasdaq climbed 0.5%, the S&P 500 added 0.4% and the Dow Jones industrial average was up 0.3%. Volume in the stock market today was tracking heavier on...
CENX: 27.90 (+0.81), AMBA: 49.67 (+0.89), GPRO: 84.10 (+2.60), MDT: 72.47 (+3.28)

Will Century Aluminum (CENX) Stock React Today to This Analyst Action?
at The Street - Tue Nov 18, 8:02AM CST
BMO Capital Markets initiated coverage of Century Aluminum (CENX) with an 'outperform' rating and a price target of $34.
CENX: 27.90 (+0.81)

Post Earnings Update: Century Aluminum Has Climbed 1.4% Higher in Past 2 Weeks (CENX)
Comtex SmarTrend(R) - Mon Nov 17, 4:03PM CST
When Century Aluminum (NASDAQ:CENX) reported earnings 19 days ago on October 29th, 2014, analysts, on average, expected the company to report earnings of $0.52 on sales of $488.8 million. Century Aluminum actually reported earnings of $0.52 per share on sales of $500.6 million, matching EPS estimates and beating revenue estimates by $11.8 million. Since the company's report, shares of Century Aluminum have risen from $27.15 to $27.53, representing a gain of 1.4% in the past 19 days.
CENX: 27.90 (+0.81)

Weakness Seen in NN Inc. (NNBR): Stock Falls 5.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:06AM CST
NN Inc. (NNBR) fell over 5% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down nearly 17% since Oct 31.
CENX: 27.90 (+0.81), WOR: 38.17 (+0.17), NNBR: 19.94 (-0.15)

General Cable (BGC) Crumbles: Stock Falls by 6.25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:49AM CDT
General Cable's shares dropped 6% yesterday , continuing the recent volatility.
CENX: 27.90 (+0.81), ARC: 9.84 (+0.40), BGC: 13.87 (+0.29), IRBT: 35.36 (+0.31)

Century Aluminum's (CENX) CEO Mike Bless on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 10:46PM CDT

CENX: 27.90 (+0.81)

Century tops Street 3Q forecasts
Automated Insights - Wed Oct 29, 5:54PM CDT
CHICAGO (AP) _ Century Aluminum Co. (CENX) on Wednesday reported third-quarter earnings of $46.3 million.
CENX: 27.90 (+0.81)

Century Aluminum (CENX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 29, 3:55PM CDT

CENX: 27.90 (+0.81)

Will GrafTech (GTI) Miss Q3 Earnings Despite Review Plans? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:17PM CDT
GrafTech International Ltd (GTI), a premium producer and retailer of carbon and graphite-mattered science-based solutions, is scheduled to release third-quarter results after the market closes on Oct 30.
CENX: 27.90 (+0.81), WOR: 38.17 (+0.17), GTI: 4.28 (+0.05), ALG: 45.51 (+0.56)

Century Aluminum EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 3:13PM CDT

CENX: 27.90 (+0.81)

Century Reports Third Quarter 2014 Financial Results
Marketwired - Wed Oct 29, 3:03PM CDT
Century Aluminum Company (NASDAQ: CENX) reported net income of $50.4 million or $0.52 per common share for the third quarter of 2014 on higher aluminum prices and lower power prices in the Midwestern U.S.
CENX: 27.90 (+0.81)

TriMas Corporation (TRS) in Focus: Stock Soars 13.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:18AM CDT
TriMas Corporation (TRS) was a big mover last session, as the company saw its shares rise by nearly 14% on the day.
CENX: 27.90 (+0.81), TRS: 31.86 (+0.49), WOR: 38.17 (+0.17)

Dynamic Materials Corp. (BOOM) Jumps: Stock Adds 6.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:11AM CDT
Dynamic Materials Corp. (BOOM) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
CENX: 27.90 (+0.81), WOR: 38.17 (+0.17), BOOM: 16.84 (-0.06)

Is Century Aluminum (CENX) Poised to Beat Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:51PM CDT
Will Century Aluminum Beat Q3 Earnings?
CENX: 27.90 (+0.81), NOR: 3.85 (-0.02), WOR: 38.17 (+0.17), RTI: 23.51 (-0.10)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:35PM CDT

CSGP: 162.61 (+3.27), CNW: 47.26 (+1.01), ACMP: 63.08 (+0.30), BGC: 13.87 (+0.29), DAC: 5.73 (-0.04), AIZ: 67.99 (+0.05), AEM: 26.88 (+1.14), ESRT: 16.25 (+0.07), CAR: 59.94 (+1.16), CWT: 24.96 (+0.28), AHL: 42.91 (+0.38), CLUB: 5.55 (+0.03), CAVM: 54.75 (+0.48), CJES: 17.98 (-0.53), FB: 74.34 (+0.10), AKAM: 62.16 (+0.13), EXR: 58.24 (+0.45), DWA: 22.48 (+0.17), EXL: 12.72 (-0.02), ANIK: 39.85 (+0.72), CLD: 12.55 (-0.21), ALL: 66.79 (+0.13), DRIV: 24.93 (+0.05), EQIX: 225.11 (+0.84), ESV: 39.18 (-0.30), ASGN: 30.60 (+0.06), AUY: 4.24 (+0.27), ACHC: 63.01 (+0.76), CALX: 10.74 (+0.06), CSII: 28.75 (+0.17), AFOP: 12.88 (-0.86), ARAY: 7.37 (+0.55), AEGN: 19.09 (+0.22), ATML: 7.57 (+0.10), CENX: 27.90 (+0.81), CUZ: 12.27 (-0.04), CACI: 84.99 (-0.64), ACGL: 56.96 (+0.05), AXS: 49.72 (+0.09), BMR: 21.36 (-0.01), ARII: 67.00 (+0.23), CBG: 33.14 (+0.62), CW: 70.73 (+0.90), DRE: 18.94 (+0.10), ABX: 13.29 (+0.82), CBL: 18.82 (+0.04), CHDN: 97.23 (+0.28), CMO: 12.84 (+0.08), CATM: 37.80 (+0.14), BLKB: 41.98 (-0.47), BIDU: 242.75 (-1.40), EQY: 23.96 (+0.06), ARRS: 28.70 (+0.53), ALDW: 17.56 (+0.18), CRUS: 18.30 (+0.08), CEMP: 13.93 (+0.30), CRL: 63.94 (+0.46)

The Zacks Analyst Blog Highlights: United States Steel, Century Aluminum, Noranda Aluminum Holding and RTI International Metals
PR Newswire - Tue Oct 28, 8:45AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the United States Steel Corp. (NYSE:X-Free Report), Century Aluminum Co. (Nasdaq:CENX-Free Report), Noranda Aluminum Holding Corp. (NYSE:NOR-Free Report) and RTI International Metals, Inc. (NYSE:RTI-Free Report).
CENX: 27.90 (+0.81)

Should You Buy Century Aluminum (CENX) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 7:54AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and Century Aluminum may be one such company as the firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report
CENX: 27.90 (+0.81)

Will IoT Market Focus Help Atmel (ATML) Beat Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 6:20PM CDT
Atmel Corporation (ATML) is scheduled to report its third-quarter 2014 results after the closing bell on Oct 29.
CENX: 27.90 (+0.81), ATML: 7.57 (+0.10), CODI: 16.98 (+0.15), ALNY: 89.95 (+0.97)

Will TriMas Corp. (TRS) Miss Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 3:22PM CDT
TriMas Corporation (TRS) is set to report third-quarter 2014 results before the opening bell on Oct 28.
CENX: 27.90 (+0.81), TRS: 31.86 (+0.49), NOR: 3.85 (-0.02), ALG: 45.51 (+0.56)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...